Not applicableStudy completedNCT00897923What this trial is testingImaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's LymphomaWho this might be right forLymphomaSmall Intestine Cancer Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT00004061What this trial is testingBiological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerWho this might be right forLeukemiaLymphomaOral Complications Memorial Sloan Kettering Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT00002657What this trial is testingSWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm SWOG Cancer Research Network 20
Not applicableStudy completedNCT00274794What this trial is testingVP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHLWho this might be right forLymphoma The Cleveland Clinic 55
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Not applicableEnded earlyNCT00608517What this trial is testingTreatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00006252What this trial is testingFludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or LymphomaWho this might be right forLeukemiaLymphoma Cancer and Leukemia Group B 47
Not applicableStudy completedNCT02037256What this trial is testingBortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple MyelomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+86 more Barbara Ann Karmanos Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT00105001What this trial is testingTacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerWho this might be right forMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more Fred Hutchinson Cancer Center 210
Early research (Phase 1)Ended earlyNCT01076556What this trial is testingCyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+9 more National Cancer Institute (NCI) 9
Not applicableStudy completedNCT00082654What this trial is testingStudy of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00004112What this trial is testingCombination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Nebraska
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00005805What this trial is testingSt. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerWho this might be right forChronic Myeloproliferative DisordersFatigueLeukemia+5 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Large-scale testing (Phase 3)UnknownNCT00020865What this trial is testingLevofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and NeutropeniaWho this might be right forFever, Sweats, and Hot FlashesInfectionLeukemia+3 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00301912What this trial is testingBusulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAnemiaChronic Myeloproliferative DisordersLeukemia+4 more University of California, San Francisco
Testing effectiveness (Phase 2)Study completedNCT00365287What this trial is testingCombination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerWho this might be right forBreast CancerKidney CancerLeukemia+3 more Masonic Cancer Center, University of Minnesota 148
Testing effectiveness (Phase 2)Study completedNCT00357084What this trial is testingMethotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantWho this might be right forCancer Fred Hutchinson Cancer Center 53